News
The FDA has approved Tryptyr (acoltremon ophthalmic solution) 0.003% for the treatment of the signs and symptoms of dry eye disease.
Introduction: Why the Starscope Monocular Is Gaining Popularity in 2025 Whether you're a nature lover, hiker, hunter, or ...
The FDA has approved Tryptyr (acoltremon) as the first TRPM8-targeting eye drop for dry eye disease, stimulating natural tear ...
To bridge these significant gaps, this paper presents a new long-distance gaze estimation paradigm: train a camera to perform eye tracking by another eye tracker, named Learning-based Single Camera ...
Alcon, a global eye care company known for products such as Systane and GenTeal Tears, plans to launch Tryptyr in the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results